107 related articles for article (PubMed ID: 3056605)
21. Bone marrow transplantation for refractory Langerhans' cell histiocytosis.
Conter V; Reciputo A; Arrigo C; Bozzato N; Sala A; Aricò M
Haematologica; 1996; 81(5):468-71. PubMed ID: 8952163
[TBL] [Abstract][Full Text] [Related]
22. Histiocytoses.
Stéphan JL
Eur J Pediatr; 1995 Aug; 154(8):600-9. PubMed ID: 7588956
[TBL] [Abstract][Full Text] [Related]
23. Histiocytosis X. Langerhans' cell histiocytosis.
Osband ME
Hematol Oncol Clin North Am; 1987 Dec; 1(4):737-51. PubMed ID: 3323181
[TBL] [Abstract][Full Text] [Related]
24. Higher in vivo protein binding of etoposide in children compared with adult cancer patients.
Liliemark E; Söderhäll S; Sirzea F; Gruber A; Osby E; Björkholm M; Zhou R; Peterson C; Liliemark J
Cancer Lett; 1996 Aug; 106(1):97-100. PubMed ID: 8827052
[TBL] [Abstract][Full Text] [Related]
25. Malignant histiocytosis X. A distinct clinicopathologic entity.
Ben-Ezra J; Bailey A; Azumi N; Delsol G; Stroup R; Sheibani K; Rappaport H
Cancer; 1991 Sep; 68(5):1050-60. PubMed ID: 1913475
[TBL] [Abstract][Full Text] [Related]
26. Phase I study of oral etoposide in children with refractory solid tumors.
Mathew P; Ribeiro RC; Sonnichsen D; Relling M; Pratt C; Mahmoud H; Bowman L; Meyer W; Avery L; Crist W
J Clin Oncol; 1994 Jul; 12(7):1452-7. PubMed ID: 8021737
[TBL] [Abstract][Full Text] [Related]
27. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
Culić S; Jakobson A; Culić V; Kuzmić I; Sćukanec-Spoljar M; Primorac D
Pediatr Hematol Oncol; 2001 Jun; 18(4):291-4. PubMed ID: 11400655
[TBL] [Abstract][Full Text] [Related]
28. [Malignant histiocytosis in children. Clinical and therapeutic aspects. Apropos of a series of 32 cases].
Brugières L; Valteau D; Patte C; Kalifa C; Hartmann O; Lemerle J
Ann Pediatr (Paris); 1989 Oct; 36(8):493-6. PubMed ID: 2817705
[TBL] [Abstract][Full Text] [Related]
29. Histologic patterns of thymic involvement in Langerhans cell proliferations: a clinicopathologic study and review of the literature.
Picarsic J; Egeler RM; Chikwava K; Patterson K; Jaffe R
Pediatr Dev Pathol; 2015; 18(2):127-38. PubMed ID: 25629953
[TBL] [Abstract][Full Text] [Related]
30. Head and neck manifestation and prognosis of Langerhans' cell histiocytosis in children.
Nicollas R; Rome A; Belaïch H; Roman S; Volk M; Gentet JC; Michel G; Triglia JM
Int J Pediatr Otorhinolaryngol; 2010 Jun; 74(6):669-73. PubMed ID: 20363036
[TBL] [Abstract][Full Text] [Related]
31. [Classifying histiocytosis, a heterogeneous group of predominantly cutaneous disorders].
Wechsler J
Ann Dermatol Venereol; 2013 Feb; 140(2):79-82. PubMed ID: 23395487
[No Abstract] [Full Text] [Related]
32. [Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study].
Gadner H; Heitger A; Ritter J; Göbel U; Janka GE; Kühl J; Bode U; Spaar HJ
Klin Padiatr; 1987; 199(3):173-82. PubMed ID: 3498085
[TBL] [Abstract][Full Text] [Related]
33. Oral etoposide for recurrent/progressive sarcomas of childhood.
Kebudi R; Görgün O; Ayan I
Pediatr Blood Cancer; 2004 Apr; 42(4):320-4. PubMed ID: 14966827
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.
Iwabuchi H; Kawashima H; Umezu H; Takachi T; Imamura M; Saitoh A; Ogose A; Imai C
Int J Hematol; 2017 Aug; 106(2):299-303. PubMed ID: 28247189
[TBL] [Abstract][Full Text] [Related]
35. Disseminated histiocytosis with undetermined Langerhans' cells simulating an acute non lymphoid leukemia.
Miano C; Bosman C; Boldrini R; DonFrancesco A; Ceci A; Mancini S; Rosati D
Haematologica; 1991; 76(3):240-2. PubMed ID: 1743596
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy of Langerhans' Cell Histiocytosis : Results and Implications of a National Patterns-of-Care Study.
Olschewski T; Seegenschmiedt MH
Strahlenther Onkol; 2006 Nov; 182(11):629-34. PubMed ID: 17072519
[TBL] [Abstract][Full Text] [Related]
37. A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.
Bracho F; Krailo MD; Shen V; Bergeron S; Davenport V; Liu-Mares W; Blazar BR; Panoskaltsis-Mortari A; van de Ven C; Secola R; Ames MM; Reid JM; Reaman GH; Cairo MS
Clin Cancer Res; 2001 Jan; 7(1):58-67. PubMed ID: 11205919
[TBL] [Abstract][Full Text] [Related]
38. Langerhans' cell histiocytosis with proliferation of immature Langerhans' cells in the deep dermis.
Akimoto S; Ishikawa O; Miyachi Y; Ogawa C
Acta Derm Venereol; 1995 Nov; 75(6):497-8. PubMed ID: 8651037
[No Abstract] [Full Text] [Related]
39. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
Duan MH; Han X; Li J; Zhang W; Zhu TN; Han B; Zhuang JL; Wang SJ; Cao XX; Cai HC; Chen M; Yang C; Zhou DB
Leuk Res; 2016 Mar; 42():43-6. PubMed ID: 26859782
[TBL] [Abstract][Full Text] [Related]
40. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
